Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 1400 participants.
Also called NCT03304496
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose supportive care
- Phase
- Phase 4
- Enrolled
- 1,400 participants
- Registry
-
NCT03304496
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Mexico
- Registry status
- Suspended
Technical summary
Registry record NCT03304496. Randomized; triple masking; primary purpose supportive care. Start 2018-03-30 (actual); primary completion 2019-03-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.
- Acronym
- NITRAD-Sub
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Nitroglycerin 100 MCG/ML Injectable Solution
- Intervention (Drug)
- Saline Solution
- Lead sponsor
- Instituto Nacional de Cardiologia Ignacio Chavez
Record details
- Record id
cardio:ct-nct03304496- Content hash
59e490dddbd5ef016bc3b03be010c84266eff9ef76381fc4297dc07e1bd50b93